Xtant Medical Holdings (XMS) Ratios
Xtant Medical Holdings Ratios
DE:XMS's free cash flow for Q2 2026 was $-7.55M. For the 2026 fiscal year, DE:XMS's free cash flow was decreased by $-247.00K and operating cash flow was $-7.31M. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Dec 24 | Mar 24 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.65 | 2.35 | 2.82 | 3.24 | 4.00 |
| Quick Ratio | 1.63 | 1.00 | 1.22 | 2.10 | 2.38 |
| Cash Ratio | 0.58 | 0.22 | 0.25 | 1.33 | 1.65 |
| Solvency Ratio | 0.24 | -0.24 | 0.09 | -0.28 | -0.15 |
| Operating Cash Flow Ratio | 0.43 | -0.42 | -0.41 | -0.35 | 0.04 |
| Short-Term Operating Cash Flow Coverage | 0.87 | -0.98 | -2.06 | -0.94 | 0.12 |
| Net Current Asset Value | $ 35.05M | $ 16.24M | $ 23.61M | $ 23.26M | $ 20.52M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.31 | 0.37 | 0.25 | 0.28 | 0.31 |
| Debt-to-Equity Ratio | 0.56 | 0.82 | 0.46 | 0.50 | 0.55 |
| Debt-to-Capital Ratio | 0.36 | 0.45 | 0.31 | 0.33 | 0.35 |
| Long-Term Debt-to-Capital Ratio | 0.18 | 0.34 | 0.25 | 0.22 | 0.28 |
| Financial Leverage Ratio | 1.85 | 2.18 | 1.80 | 1.76 | 1.77 |
| Debt Service Coverage Ratio | 0.77 | -0.50 | 0.90 | -0.74 | -0.54 |
| Interest Coverage Ratio | 1.98 | -2.90 | -3.46 | -3.99 | -3.87 |
| Debt to Market Cap | 0.23 | 0.58 | 0.16 | 0.25 | 0.32 |
| Interest Debt Per Share | 0.23 | 0.29 | 0.22 | 0.20 | 0.21 |
| Net Debt to EBITDA | 0.73 | -3.67 | 3.52 | 0.59 | 0.56 |
| Profitability Margins | |||||
| Gross Profit Margin | 62.92% | 58.17% | 60.75% | 55.44% | 58.79% |
| EBIT Margin | 7.97% | -10.32% | 2.08% | -11.60% | -6.97% |
| EBITDA Margin | 11.87% | -6.72% | 5.56% | -9.36% | -4.55% |
| Operating Profit Margin | 5.44% | -10.30% | -11.13% | -11.65% | -6.97% |
| Pretax Profit Margin | 5.23% | -13.87% | -1.14% | -14.52% | -8.77% |
| Net Profit Margin | 3.71% | -14.03% | 0.72% | -14.64% | -8.77% |
| Continuous Operations Profit Margin | 3.71% | -14.03% | 0.72% | -14.64% | -8.77% |
| Net Income Per EBT | 71.03% | 101.15% | -63.65% | 100.82% | 100.00% |
| EBT Per EBIT | 96.11% | 134.69% | 10.21% | 124.59% | 125.82% |
| Return on Assets (ROA) | 5.28% | -17.53% | 0.71% | -14.09% | -8.87% |
| Return on Equity (ROE) | 9.76% | -38.29% | 1.29% | -24.83% | -15.70% |
| Return on Capital Employed (ROCE) | 11.26% | -18.50% | -14.59% | -15.01% | -8.84% |
| Return on Invested Capital (ROIC) | 6.49% | -15.45% | 8.60% | -13.18% | -8.07% |
| Return on Tangible Assets | 5.67% | -21.04% | 0.88% | -14.97% | -9.49% |
| Earnings Yield | 4.55% | -27.78% | 0.49% | -13.66% | -10.13% |
| Efficiency Ratios | |||||
| Receivables Turnover | 7.52 | 5.68 | 4.40 | 5.34 | 7.72 |
| Payables Turnover | 12.92 | 6.19 | 5.08 | 7.40 | 8.71 |
| Inventory Turnover | 1.64 | 1.27 | 0.97 | 1.49 | 1.27 |
| Fixed Asset Turnover | 14.26 | 10.70 | 8.94 | 8.09 | 8.54 |
| Asset Turnover | 1.42 | 1.25 | 0.99 | 0.96 | 1.01 |
| Working Capital Turnover Ratio | 3.07 | 2.92 | 2.40 | 1.72 | 2.84 |
| Cash Conversion Cycle | 242.72 | 292.87 | 386.71 | 263.26 | 292.96 |
| Days of Sales Outstanding | 48.52 | 64.31 | 82.88 | 68.34 | 47.25 |
| Days of Inventory Outstanding | 222.46 | 287.48 | 375.68 | 244.23 | 287.62 |
| Days of Payables Outstanding | 28.26 | 58.92 | 71.85 | 49.31 | 41.91 |
| Operating Cycle | 270.98 | 351.79 | 458.56 | 312.57 | 334.87 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.09 | -0.09 | -0.08 | -0.06 | 0.01 |
| Free Cash Flow Per Share | 0.07 | -0.12 | -0.09 | -0.08 | -0.02 |
| Dividend Paid and CapEx Coverage Ratio | 5.27 | -2.89 | -6.54 | -3.03 | 0.21 |
| Capital Expenditure Coverage Ratio | 5.27 | -2.89 | -6.54 | -3.03 | 0.21 |
| Operating Cash Flow Coverage Ratio | 0.44 | -0.34 | -0.40 | -0.31 | 0.03 |
| Operating Cash Flow to Sales Ratio | 0.09 | -0.10 | -0.10 | -0.09 | 0.01 |
| Free Cash Flow Yield | 9.29% | -27.04% | -8.15% | -11.44% | -3.50% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 19.60 | -3.69 | 203.90 | -7.32 | -9.87 |
| Price-to-Sales (P/S) Ratio | 0.82 | 0.50 | 1.47 | 1.07 | 0.87 |
| Price-to-Book (P/B) Ratio | 2.15 | 1.38 | 2.62 | 1.82 | 1.55 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 10.76 | -3.70 | -12.27 | -8.74 | -28.55 |
| Price-to-Operating Cash Flow Ratio | 8.72 | -4.98 | -14.14 | -11.63 | 109.01 |
| Price-to-Earnings Growth (PEG) Ratio | -0.15 | 0.00 | -1.92 | -0.12 | 0.13 |
| Enterprise Value Multiple | 7.62 | -11.19 | 30.03 | -10.85 | -18.49 |
| Enterprise Value | 121.06M | 88.16M | 152.42M | 58.87M | 46.46M |
| EV to EBITDA | 7.62 | -11.19 | 30.03 | -10.85 | -18.49 |
| EV to Sales | 0.90 | 0.75 | 1.67 | 1.02 | 0.84 |
| EV to Free Cash Flow | 11.91 | -5.51 | -13.89 | -8.29 | -27.72 |
| EV to Operating Cash Flow | 9.65 | -7.41 | -16.02 | -11.02 | 105.83 |
| Tangible Book Value Per Share | 0.32 | 0.20 | 0.29 | 0.33 | 0.32 |
| Shareholders’ Equity Per Share | 0.37 | 0.32 | 0.43 | 0.36 | 0.36 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.29 | -0.01 | 1.64 | -0.01 | 0.00 |
| Revenue Per Share | 0.96 | 0.88 | 0.77 | 0.62 | 0.65 |
| Net Income Per Share | 0.04 | -0.12 | 0.01 | -0.09 | -0.06 |
| Tax Burden | 0.71 | 1.01 | -0.64 | 1.01 | 1.00 |
| Interest Burden | 0.66 | 1.34 | -0.55 | 1.25 | 1.26 |
| Research & Development to Revenue | 0.02 | 0.02 | 0.01 | 0.02 | 0.02 |
| SG&A to Revenue | 0.56 | 0.66 | 0.28 | 0.27 | 0.26 |
| Stock-Based Compensation to Revenue | 0.02 | 0.04 | 0.03 | 0.04 | 0.04 |
| Income Quality | 2.52 | 0.72 | -14.42 | 0.63 | -0.09 |
Currency in USD
